Regeneron Pharmaceuticals (REGN) stock valuation

$958.18 Nov 18, 2026 · market cap $104B

14/121 investors
i

Regeneron Pharmaceuticals trades at $958. Our three models put it at $789–$1,615 (base $994): 4% below the base.

Damodaran $1,615 · Buffett $994 · Cash Flow $789 · models run Nov 18, 2026

14 of 121 tracked investors hold it · Q3 2026 13F filings

Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app

5 AI analysts debate REGNCreate free account →

Full open-source research report for REGN on DeepValues Research (CC BY 4.0)